Clinical Trials Directory

Trials / Completed

CompletedNCT05304884

Ozone Injection for Shoulder Impengement Syndrome

Clinical and Functional Outcomes of a Single Dose Ozone, Three Doses of Ozone and Corticosteroid Injection in Patients With Shoulder Impingement Syndrome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Erzurum Regional Training & Research Hospital · Other Government
Sex
Age
Healthy volunteers
Not accepted

Summary

Ozone injection has lately been utilized as a safe alternative to corticosteroids in the management of musculoskeletal diseases with fewer side effects. This study aimed to compare the effectiveness of a corticosteroid, single dose and three doses of ozone injection in shoulder impingement syndrome (SIS).

Detailed description

A hundred and eight SIS patients were divided into three groups and underwent subacromial injections in this prospective study. Group 1 received a single dose (n:36), group 2 (n:36) received three doses of ozone injection (n :36). Group 3 (n:36) was treated with a corticosteroid injection. Patients were evaluated using the visual analog scale (VAS) and Constant Murley Score (CMS), pre-injection and at 4 weeks and 12 weeks.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTcombined oxygen-ozone and corticosteroidSubacromial injection using Ultrasound

Timeline

Start date
2021-06-30
Primary completion
2022-02-22
Completion
2022-03-22
First posted
2022-03-31
Last updated
2022-03-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05304884. Inclusion in this directory is not an endorsement.